Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_assertion type Assertion NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_head.
- NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_assertion description "[MTC02 expression was associated with advanced pathological tumor stage, high Gleason score, nodal metastases (p?<?0.0001 each), positive surgical margins (p?=?0.0005), and early PSA recurrence (p?<?0.0001) if all cancers were jointly analyzed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_provenance.
- NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_assertion evidence source_evidence_literature NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_provenance.
- NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_assertion SIO_000772 24261794 NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_provenance.
- NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_assertion wasDerivedFrom befree-2016 NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_provenance.
- NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_assertion wasGeneratedBy ECO_0000203 NP1130318.RAsvg0nuK4Uc05D9GuFVeQ_Qv418J5-SMLoqXhwKhcM8k130_provenance.